Nutritional condition abnormal
(UMLS:C1611727)
- UMLS ID:
- C1611727
- MeSH ID:
- N/A
Synonym(s)
1.
Nutritional condition abnormal
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 10 | US FAERS | |
| 2 | rofecoxib | FAERS: 7 | US FAERS | |
| 3 | Metformin | FAERS: 4 | US FAERS | |
| 4 | carbidopa, levodopa drug combination | FAERS: 4 | US FAERS | |
| 5 | Sunitinib | FAERS: 3 | US FAERS | |
| 6 | Ciprofloxacin | FAERS: 2 | US FAERS | |
| 7 | Erlotinib Hydrochloride | FAERS: 2 | US FAERS | |
| 8 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 9 | Rabeprazole | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 10 | Teriparatide | FAERS: 2 | US FAERS | |
| 11 | Thalidomide | FAERS: 2 | US FAERS | |
| 12 | Valsartan | FAERS: 2 | US FAERS | |
| 13 | Afatinib | FAERS: 1 | US FAERS | |
| 14 | Allopurinol | FAERS: 1 | US FAERS | |
| 15 | Aripiprazole | FAERS: 1 | US FAERS | |
| 16 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 17 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 18 | Clozapine | FAERS: 1 | US FAERS | |
| 19 | Copper | FAERS: 1 | US FAERS | |
| 20 | Cyclosporine | FAERS: 1 | US FAERS | |
| 21 | Deferasirox | FAERS: 1 | US FAERS | |
| 22 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 23 | Finasteride | FAERS: 1 | US FAERS | |
| 24 | Idarubicin | FAERS: 1 | US FAERS | |
| 25 | LCZ 696 | FAERS: 1 | US FAERS | |
| 26 | Lenalidomide | FAERS: 1 | US FAERS | |
| 27 | Levetiracetam | FAERS: 1 | US FAERS | |
| 28 | Levofloxacin | FAERS: 1 | US FAERS | |
| 29 | Lisdexamfetamine Dimesylate | FAERS: 1 | US FAERS | |
| 30 | Loperamide | FAERS: 1 | US FAERS | |
| 31 | Memantine | FAERS: 1 | US FAERS | |
| 32 | Methotrexate | FAERS: 1 | US FAERS | |
| 33 | Temozolomide | FAERS: 1 | US FAERS | |
| 34 | Triumeq | FAERS: 1 | US FAERS | |
| 35 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 36 | lenvatinib | FAERS: 1 | US FAERS | |
| 37 | linaclotide | FAERS: 1 | US FAERS | |
| 38 | nitisinone | FAERS: 1 | US FAERS | |
| 39 | palbociclib | FAERS: 1 | US FAERS | |
| 40 | pirfenidone | FAERS: 1 | US FAERS | |
| 41 | regorafenib | FAERS: 1 | US FAERS | |
| 42 | reviparin | FAERS: 1 | US FAERS | |
| 43 | teduglutide | FAERS: 1 | US FAERS | |
| 44 | tegaserod | FAERS: 1 | US FAERS | |
| 45 | Acebutolol | OFFSIDES | ||
| 46 | Acetylcysteine | OFFSIDES | ||
| 47 | Azacitidine | OFFSIDES | ||
| 48 | Benztropine | OFFSIDES | ||
| 49 | Bosentan | OFFSIDES | ||
| 50 | Cefazolin | OFFSIDES | ||
| 51 | Cephalexin | OFFSIDES | ||
| 52 | Chlorhexidine | OFFSIDES | ||
| 53 | Cimetidine | OFFSIDES | ||
| 54 | Clobazam | OFFSIDES | ||
| 55 | Diphenoxylate | OFFSIDES | ||
| 56 | Estramustine phosphate | OFFSIDES | ||
| 57 | Estramustine | OFFSIDES | ||
| 58 | Ethambutol | OFFSIDES | ||
| 59 | Etodolac | OFFSIDES | ||
| 60 | Etomidate | OFFSIDES | ||
| 61 | Fluphenazine | OFFSIDES | ||
| 62 | Goserelin | OFFSIDES | ||
| 63 | Granisetron | OFFSIDES | ||
| 64 | Hydrochlorothiazide | OFFSIDES | ||
| 65 | Hydrocodone | OFFSIDES | ||
| 66 | Midazolam | OFFSIDES | ||
| 67 | Neostigmine | OFFSIDES | ||
| 68 | Nicardipine | OFFSIDES | ||
| 69 | Paclitaxel | OFFSIDES | ||
| 70 | Paroxetine | OFFSIDES | ||
| 71 | Pramipexole | OFFSIDES | ||
| 72 | Ritonavir | OFFSIDES | ||
| 73 | Rosuvastatin Calcium | OFFSIDES | ||
| 74 | Rosuvastatin Calcium | OFFSIDES | ||
| 75 | Sildenafil Citrate | OFFSIDES | ||
| 76 | Stavudine | OFFSIDES | ||
| 77 | Succinylcholine | OFFSIDES | ||
| 78 | Trichlormethiazide | OFFSIDES | ||
| 79 | Vincristine | OFFSIDES | ||
| 80 | chlorhexidine gluconate | OFFSIDES | ||
| 81 | dolasetron | OFFSIDES | ||
| 82 | fludarabine | OFFSIDES | ||
| 83 | rebamipide | OFFSIDES | ||
| 84 | repaglinide | OFFSIDES | ||
| 85 | roxatidine acetate | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.